Ouro Medicines
Christina Carlson serves as the General Counsel and Chief Administrative Officer at Ouro Medicines, bringing extensive legal expertise from prior roles. At HI-Bio, a Biogen Company, Christina held the position of General Counsel. Christina's previous experience includes serving as Vice President of Corporate Legal at Gilead Sciences and working as a Technology Transaction Associate at Wilson Sonsini Goodrich and Rosati.
This person is not in any teams
This person is not in any offices
Ouro Medicines
Ouro Medicines is dedicated to developing immune reset therapeutics for people living with chronic immune-mediated diseases. Our approach is focused on leveraging T cell engagers in B cell mediated diseases to achieve immune resets that enable durable remissions without ongoing immunosuppression for patients. Based in San Francisco, Ouro was founded by Monograph Capital in partnership with GSK. We are also backed by leading investors TPG, NEA, Norwest and more.